It is interesting to note that the mechanism by which hepatic Adgrf1 transcription is repressed in healthy obese individuals and induced in NAFLD patients remains to be explored. This evidence concerns the gene ADGRF1 and metabolic dysfunction-associated steatotic liver disease.